These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanical stress and formation of protein aggregates in neurodegenerative disorders. Hachiya NS, Kozuka Y, Kaneko K. Med Hypotheses; 2008 Feb; 70(5):1034-7. PubMed ID: 17910993 [Abstract] [Full Text] [Related]
8. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Gaggelli E, Kozlowski H, Valensin D, Valensin G. Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441 [No Abstract] [Full Text] [Related]
9. Branched chain mechanism of polymerization and ultrastructure of prion protein amyloid fibrils. Baskakov IV. FEBS J; 2007 Aug; 274(15):3756-65. PubMed ID: 17617227 [Abstract] [Full Text] [Related]
10. Novel therapeutic strategies for the treatment of protein-misfolding diseases. Rochet JC. Expert Rev Mol Med; 2007 Jun 28; 9(17):1-34. PubMed ID: 17597554 [Abstract] [Full Text] [Related]
11. Amyloid peptides and proteins in review. Harrison RS, Sharpe PC, Singh Y, Fairlie DP. Rev Physiol Biochem Pharmacol; 2007 Jun 28; 159():1-77. PubMed ID: 17846922 [Abstract] [Full Text] [Related]
12. [Conformationally altered proteins cause neurodegenerative diseases]. Ingelsson M, Nilsson L, Basun H, Aquilonius SM, Lannfelt L. Lakartidningen; 2007 Jun 28; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392 [Abstract] [Full Text] [Related]
14. [Prion proteins: folding and aggregation properties]. Bousset L, Melki R. Med Sci (Paris); 2005 Jun 28; 21(6-7):634-40. PubMed ID: 15985207 [Abstract] [Full Text] [Related]
15. The reconstitution of mammalian prion infectivity de novo. Baskakov IV. FEBS J; 2007 Feb 28; 274(3):576-87. PubMed ID: 17288547 [Abstract] [Full Text] [Related]
19. Protein aggregation and prionopathies. Renner M, Melki R. Pathol Biol (Paris); 2014 Jun 28; 62(3):162-8. PubMed ID: 24698014 [Abstract] [Full Text] [Related]